TY  - GEN
AU  - Weiss,Glen J
AU  - Hidalgo,Manuel
AU  - Borad,Mitesh J
AU  - Laheru,Daniel
AU  - Tibes,Raoul
AU  - Ramanathan,Ramesh K
AU  - Blaydorn,Lisa
AU  - Jameson,Gayle
AU  - Jimeno,Antonio
AU  - Isaacs,Jeffrey D
AU  - Scaburri,Angela
AU  - Pacciarini,Maria Adele
AU  - Fiorentini,Francesco
AU  - Ciomei,Marina
AU  - Von Hoff,Daniel D
TI  - Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies
SN  - 1573-0646
PY  - 2013///0404
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Cyclin-Dependent Kinases
KW  - antagonists & inhibitors
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Protein Kinase Inhibitors
KW  - administration & dosage
KW  - Pyrazoles
KW  - Quinazolines
KW  - Receptor, trkA
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study
UR  - https://doi.org/10.1007/s10637-011-9774-6
ER  -